SCHEMBL7512633

SCHEMBL7512633

N#Cc1ccc(OC(N)=O)c(O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR1 P25024 2/20 0.40
CXCR2 P25025 2/20 0.40
PARP15 Q460N3 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.39
NCEH1 Q6PIU2 2/20 0.39
P4HB P07237 1/20 0.39
USP30 Q70CQ3 1/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
CA12 O43570 1/20 0.36
CA3 P07451 1/20 0.36
CA6 P23280 1/20 0.36
CA14 Q9ULX7 1/20 0.36
MMP2 P08253 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CA1 P00915 1/20 0.36
GSK3B P49841 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27336403 0.83 PTGDR2 (0.40) PARP15PARP10PARP2PTGDR2NCEH1
SCHEMBL28209125 0.81 USP30 (0.53) PARP15PARP10PARP2PTGDR2NCEH1
SCHEMBL15495941 0.79 NCEH1 (0.39) CXCR1CXCR2PTGDR2NCEH1P4HB
SCHEMBL19558272 0.79 ELANE (0.42) CXCR1CXCR2NCEH1P4HB
SCHEMBL13724523 0.74 MAPT (0.47) PTGDR2CA2MEN1KMT2ACA1
SCHEMBL388024 0.74 AR (0.51) P4HBCA2CA1
SCHEMBL28057940 0.74 P4HB (0.39) CXCR1CXCR2PTGDR2NCEH1P4HB
SCHEMBL28426175 0.73 ALOX15 (0.43) PTGDR2MEN1KMT2A
Methyl Alcohol SCHEMBL27451617 0.73 AR (0.50) P4HB
SCHEMBL3371911 0.73 TRPA1 (0.45) CA2CA9MEN1KMT2ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261611-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-12-04 EP disclosed
EP-1107948-A4 AN IMPROVED SYNTHESIS OF 3-HYDROXY-4-AMINO-BENZONITRILE SMITHKLINE BEECHAM (US) 2002-01-02 EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 WO disclosed
EP-1107948-A1 AN IMPROVED SYNTHESIS OF 3-HYDROXY-4-AMINO-BENZONITRILE Smithkline Beecham (US) 2001-06-20 EP disclosed
WO-2000012468-A1 AN IMPROVED SYNTHESIS OF 3-HYDROXY-4-AMINO-BENZONITRILE SMITHKLINE BEECHAM CORPORATION (US) 2000-03-09 WO disclosed